

Saccharomyces cerevisiae is a normally harmless yeast found in the body and the environment. In some people, however, the immune system reacts by producing antibodies against it. These antibodies, known as anti-Saccharomyces cerevisiae antibodies (ASCA), are commonly linked with Crohn’s disease. Detecting ASCA-IgG in the blood helps differentiate Crohn’s disease from ulcerative colitis. While both conditions fall under the category of IBD, they affect different regions of the gastrointestinal tract and often require distinct treatment approaches.
The ASCA - IgG antibody test is recommended for individuals showing gastrointestinal symptoms such as persistent diarrhea, abdominal pain, weight loss, or rectal bleeding, especially when the clinical features do not clearly point towards either ulcerative colitis or Crohn’s disease. It is also valuable in cases with atypical or overlapping IBD symptoms where additional diagnostic information is needed. By identifying elevated ASCA-IgG levels, clinicians can tailor treatment more precisely to the patient’s condition.
No special preparation is needed for getting the ASCA - IgG antibody test done. However, be sure to inform the doctor about any medications or supplements being taken, as they may affect the test results.
Lab test results may vary across different laboratories. Abnormal test results require expert interpretation. Therefore, never try to self-medicate based solely on these results. Always consult a doctor for a proper understanding of the test resul
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The ASCA - IgG antibody test detects the presence of IgG antibodies produced by the immune system in response to Saccharomyces cerevisiae. These antibodies are usually present at very low levels in healthy individuals. Elevated IgG antibody levels suggest an abnormal immune reaction to yeast antigens, which is strongly associated with Crohn’s disease. While a positive result does not confirm the disease on its own, it provides supportive evidence when correlated with clinical signs and other laboratory tests. This test does not diagnose ulcerative colitis but can help differentiate between Crohn’s disease and ulcerative colitis, as ASCA positivity is far more common in Crohn’s disease.
The ASCA - IgG antibody test is done:
- To help distinguish between ulcerative colitis and Crohn’s disease
- To provide additional diagnostic support when IBD symptoms are unclear
- To guide treatment strategies based on the specific type of IBD and helps in monitoring of treatment
- To confirm Crohn’s disease before starting targeted therapies
- No special preparation is required.































